IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,557,000 | +29.9% | 3,643,000 | +25.5% | 0.00% | 0.0% |
Q2 2023 | $2,738,000 | -10.7% | 2,903,000 | -14.1% | 0.00% | 0.0% |
Q1 2023 | $3,066,000 | -41.3% | 3,378,000 | -40.2% | 0.00% | 0.0% |
Q4 2022 | $5,219,000 | +17.8% | 5,653,000 | +26.1% | 0.00% | 0.0% |
Q3 2022 | $4,430,000 | – | 4,483,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 127,800,000 | $118,341,522 | 2.45% |
Boussard & Gavaudan Investment Management LLP | 17,500 | $16,097,175 | 1.78% |
BRAIDWELL LP | 52,740,000 | $48,949,313 | 1.64% |
WOLVERINE ASSET MANAGEMENT LLC | 109,030,000 | $101,603,446 | 1.05% |
Sonora Investment Management Group, LLC | 9,195,000 | $8,531,756 | 0.78% |
CSS LLC/IL | 11,966,000 | $11,133,286 | 0.63% |
MACKAY SHIELDS LLC | 24,332,000 | $22,563,542 | 0.58% |
SSI INVESTMENT MANAGEMENT LLC | 6,935,000 | $6,401,874 | 0.41% |
ADVENT CAPITAL MANAGEMENT /DE/ | 18,450,000 | $17,123,906 | 0.30% |
Magnetar Financial LLC | 16,700,000 | $15,510 | 0.26% |